Does mild renal failure affect coronary flow reserve after coronary artery bypass graft surgery?

Murat Günday1, Özgür Çiftçi2, Mustafa Çalışkan2

  • 1Faculty of Medicine, Department of Cardiovascular Surgery, Baskent University, Ankara, Turkey.

Insights

Mild renal failure in patients undergoing coronary artery bypass grafting (CABG) is linked to reduced coronary flow reserve (CFR), indicating potential microvascular damage. This finding highlights the importance of considering kidney function in cardiovascular disease management.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Biology

Background:

  • Limited research exists on the association between mild renal failure and coronary artery disease (CAD).
  • Mild renal failure may impact the distal vascular bed, affecting coronary circulation.
  • Coronary artery bypass grafting (CABG) is a common procedure for CAD, but its outcomes may be influenced by renal function.

Purpose of the Study:

  • To investigate the effects of mild renal failure on the distal vascular bed in patients undergoing CABG.
  • To measure coronary flow reserve (CFR) using transthoracic echocardiography in patients with varying degrees of renal function.
  • To assess the relationship between preoperative renal function and postoperative CFR after CABG.

Main Methods:

  • A cohort of 52 patients who underwent uncomplicated CABG was studied.
  • Patients were categorized into two groups based on preoperative glomerular filtration rate (GFR): mild renal failure (GFR 60-90) and normal renal function (GFR >90).
  • Coronary flow reserve (CFR) was measured using second harmonic transthoracic Doppler echocardiography before and after CABG.

Main Results:

  • Patients with mild renal failure (Group 1) had a significantly lower preoperative CFR (1.79 ± 0.06) compared to those with normal renal function (Group 2, 2.05 ± 0.09).
  • Postoperative CFR also showed a significant difference between groups, with Group 1 having lower CFR (2.09 ± 0.08) than Group 2 (2.37 ± 0.06).
  • A significant increase in CFR was observed post-CABG across both groups, but the preoperative deficit in the mild renal failure group persisted.

Conclusions:

  • Mild renal failure is associated with a decreased coronary flow reserve in patients undergoing CABG.
  • Deterioration of the microvascular bed in patients with mild renal failure may contribute to adverse effects following CABG.
  • These findings suggest that renal function should be carefully considered in the management of patients with coronary artery disease.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632